ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Pfizer CentreSource (PCS), the contract manufacturing division of Pfizer, says its Heumann PCS business will be sold as part of Pfizer's previously announced plan to divest its Feucht, Germany, manufacturing site. Michael J. Kosko, president of PCS, says Heumann produces specialty pharmaceutical chemicals such as high-containment and high-potency compounds. "The planned sale does not impact the fine chemicals and contract manufacturing business units, which focus on steroids and drug products, respectively," Kosko says.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X